Articles

The effect of zidovudine on neuropsychiatric measures in HIV-infected men

Gorman, JM; Mayeux, R; Stern, Yaakov; Williams, JB; Rabkin, J; Goetz, RR; Ehrhardt, AA

The authors examined the effects of zidovudine on neuropsychiatric measures, at three assessment points separated by 6 months, in 25 HIV- positive men who took zidovudine for at least 6 months and a comparison group of 25 HIV-positive men with similar CD4+ T cell counts who had never taken zidovudine. Zidovudine had no statistically significant effect except for a slight improvement in Global Assessment of Functioning scale score. In this small group of subjects there was little benefit but also little evidence of CNS toxicity from zidovudine.

Subjects

Files

  • thumnail for 1993 - The effect of zidovudine on neuropsychiatric measu.pdf 1993 - The effect of zidovudine on neuropsychiatric measu.pdf application/pdf 279 KB Download File

Also Published In

Title
American Journal of Psychiatry
DOI
https://doi.org/10.1176/ajp.150.3.505

More About This Work

Academic Units
Neurology
Published Here
February 11, 2022